Biochimpharm Financial Model
Biochimpharm
Biochemistry is a phage-producing company which is aimed at maximizing the long-term experience of phagicides in order to simplify the fight against bacterial infections.
SavvY created a financial model for a new production unit of Biochimpharm and evaluated the existing project: its investment volume, assumptions, profitability, cost, and revenue structure. Using a 5-year financial model, the company’s project was assessed reliably for investors.